| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |